Pyrroloquinoline quinone-secreting probiotic escherichia coli nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 7, 2014, Pages 2127-2137

  Singh, Ashish K ^a   Pandey, Sumeet K ^a   Naresh Kumar, Gattupalli ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

E. coli nissle 1917; Ethanol; Hyperlipidemia; Oxidative damage; Pyrroloquinoline quinone

Indexed keywords

ALCOHOL; ANTIOXIDANT; ASCORBIC ACID; PROBIOTIC AGENT; PYRROLOQUINOLINEQUINONE;

ANIMAL; CHEMICALLY INDUCED; DIET THERAPY; DRUG ADMINISTRATION; DRUG EFFECTS; ESCHERICHIA COLI; HYPERLIPIDEMIAS; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; RAT; SECRETION (PROCESS);

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; DRUG ADMINISTRATION SCHEDULE; ESCHERICHIA COLI; ETHANOL; HYPERLIPIDEMIAS; LIVER; MALE; OXIDATIVE STRESS; PQQ COFACTOR; PROBIOTICS; RATS;

EID: 84904393604     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12456     Document Type: Article

References (51)

1. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K (2010) Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochem Biophys Acta 1801:1175-1178.
2. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A (1999) Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 291:1075-1085.
3. Baraona E, Lieber CS (1979) Effects of ethanol on lipid metabolism. J Lipid Res 20:289-315.
4. Bauerly K, Harris C, Chowanadisai W, Graham J, Havel PJ, Tchaparian E, Satre M, Karliner JS, Rucker RB (2011) Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One 6:e21779.
5. Beers RF, Sizer IW (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:130-140.
6. Beutler E, Duron O, Kelly BM (1969) Improved method for the reduced glutathione. J Lab Clin Med 61:882-888.
7. Brooks PJ, Theruvathu JA (2005) DNA adducts from acetaldehyde: implications for alcohol related carcinogenesis. Alcohol 35:187-193.
8. Buege JA, Aust SD (1978) Microsomal lipid peroxidation methods. Enzymology 52:302-310.
9. Canani RB, Costanzo MD, Leone L, Petada M, Meli R, Calignano A (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17:1519-1528.
10. Chen H-M, Lifachitz CH (1989) Preparation of fecal samples for assay of volatile fatty acids by gas-liquid chromatography and high performance liquid chromatography. Clin Chem 35:74-76.
11. Crouse JR, Grundy SM (1984) Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lipid Res 25:486-496.
12. Dunagan M, Chaudhry K, Samak G, Rao RK (2012) Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 303:G1356-G1364.
13. French SW, Wong K, Jui L, Albano E, Hagbjork AL, Ingelman-Sundberg M (1993) Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol 58:61-75.
14. Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572-1585.
15. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR (2006) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect Immun 74:4075-4082.
16. Gyaneshwar P, Parekh LJ, Archana G, Poole PS, Collins MD, Huston RA, Naresh Kumar G (1999) Involvement of a phosphate starvation inducible glucose dehydrogenase in soil phosphate solubilization by Enterobacter asburiae. FEMS Microbiol Lett 171:223-229.
17. Hobara N, Watanabe A, Kobayashi M, Tsuji T, Gomita Y, Araki Y (1988) Quinone derivatives lower blood and liver acetaldehyde but not ethanol concentrations following ethanol loading to rats. Pharmacology 37:264-267.
18. Kallio PT, Kim DJ, Tsai PS, Bailey JE (1994) Intracellular expression of Vitreoscilla haemoglobin activates E. coli energy metabolism under oxygen-limited conditions. Eur J Biochem 219:201-208.
19. Kameue C, Tsukahara T, Yamada K, Koyama H, Iwasaki Y, Nakayama K, Ushida K (2004) Dietary sodium gluconate protects rats from large bowel cancer by stimulating butyrate production. J Nutr 134:940-944.
20. Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farre S, Galeotti T (2004) Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med 25:191-198.
21. Kondo T, Kishi M, Fushimi T, Kaga T (2009) Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. J Agric Food Chem 57:5982-5986.
22. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM 2nd Peterson KM (1995) Four new derivatives of a broad host range cloning vector pRRE1MCS, carrying different antibiotic resistance cassettes. Gene 166:175-176.
23. Kumazawa T, Seno H, Urakami T, Matsumato T, Suzuki O (1992) Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectroscopy. Biochim Biophys Acta 1156:62-66.
24. Kvist M, Ryabova ES, Nordlander E, Bulow L (2007) An investigation of peroxidase activity of Vitreoscilla hemoglobin. J Biol Inorg Chem 12:324-334.
25. Lee SJ, Kim SY, Min H (2013) Effects of vitamin C and E supplementation on oxidative stress and liver toxicity in rats fed a low-fat ethanol diet. Nutr Res Pract 7:109-114.
26. Lieber CS (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)-a review. Alcohol Clin Exp Res 23:991-1007.
27. Lundquist BF, Tygstrup N, Winkler K, Mellemgaard K, Petersen SM (1962) Ethanol metabolism and production of free acetate in the human liver. J Clin Invest 41:955-961.
28. Marklund S, Marklund G (1974) Involvement of superoxide ion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474.
29. Matsushita K, Arents JC, Bader R, Yamada M, Adachi O, Postma PW (1997) Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ). Microbiology 143:3149-3156.
30. McKenzie GJ, Craig NL (2006) Fast, easy and efficient: site-specific insertion of transgenes into enterobacterial chromosomes using Tn7 without need for selection of the insertion event. BMC Microbiol 6:39.
31. Mitchell AE, Jones AD, Mercer RS, Rucker RB (1999) Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem 269:317-325.
32. 2, a reduced form of pyrroloquinolinequinone) in micellar solution. J Agric Food Chem 59:1705-1712.
33. Niemela O (2001) Serial review: alcohol, oxidative stress and cell injury distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radical Biol Med 31:1533-1538.
34. Oh SI, Kim C, Chun HJ, Lee MS, Park SC (1997) Glutathione recycling is attenuated by acute ethanol feeding in rat liver. J Korean Med Sci 12:316-321.
35. Pandey S, Singh A, Kumar P, Chaudhari A, Naresh Kumar G (2014) Probiotic Escherichia coli CFR 16 producing pyrroloquinoline quinone (PQQ) ameliorates 1, 2-Dimethylhydrazine induced oxidative damage in colon and liver of rats. Appl Biochem Biotechnol doi: 10.1007/s12010-014-0897-z.
36. Rajpurohit YS, Gopalakrishnan R, Misra HS (2008) Involvement of a protein kinase activity inducer in DNA double strand break repair and radioresistance of Deinococcus radiodurans. J Bacteriol 190:3948-3954.
37. Rucker R, Chowanadisai W, Nakano M (2009) Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev 14:268-277.
38. Sambrook J, Maccallum P, Russel D (2001) Molecular Cloning: A Laboratory Manual. 3rd ed., Vol. 1. Cold Springs Harbour Press, New York.
39. Schultz M (2008) Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis 14:1012-1018.
40. Seo EJ, Weibel S, Wehkamp J, Oelschlaeger TA (2012) Construction of recombinant E. coli Nissle (EcN) strains for expression and secretion of defensins. Int J Med Microbiol 302:276-287.
41. Sonnenborn U, Schulze J (2009) The non-pathogenic Escherichia coli strain Nissle 1917 - features of a versatile probiotic. Microb Ecol Health Dis 21:122-158.
42. Suzuki O, Kumazawa T, Seno H (1990) Extractions of pyrroloquinoline quinone from crude biological samples. Life Sci 47:2135-2141.
43. Urakami T, Yoshida C, Akaike T, Maeda H, Nishigori H, Niki E (1997) Synthesis of monoesters of pyrroloquinoline quinine and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol 43:19-33.
44. Wang AL, Wang JP, Wang H, Chen YH, Zhao L, Wang LS, Wei W, Xu DX (2006) A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice. Hepatol Res 34:199-206.
45. Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, Feng W (2011) Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 179:2866-2875.
46. Xu F, Yu H, Liu J, Cheng L (2014) Pyrroloquinoline quinone inhibits oxygen/glucose deprivation-induced apoptosis by activating the PI3K/AKT pathway in cardiomyocytes. Mol Cell Biochem 386:107-115.
47. Yang XP, Zhong GF, Lin JP, Mao DB, Wei DZ (2010) Pyrroloquinoline quinone biosynthesis in Escherichia coli through expression of the Gluconobacter oxydans pqqABCDE gene cluster. J Ind Microbiol Biotechnol 37:575-580.
48. You M, Fischer M, Deeg MA, Crabb DW (2002) Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277:29342-29347.
49. Zhang Y, Rosenberg PA (2002) The essential nutrient pyrroloquinoline quinine may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci 16:1015-1024.
50. Zhang Y, Zhang Y, Xia L, Zhang X, Ding X, Yan F, Wu F (2012) Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol 78:7603-7610.
51. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA (2007) Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9:804-816.